200,000+ products from a single source!

sales@angenechem.com

Home > Engineering of a chromogenic enzyme screening system based on an auxiliary indole‐3‐carboxylic acid monooxygenase

Engineering of a chromogenic enzyme screening system based on an auxiliary indole‐3‐carboxylic acid monooxygenase

 

 

Vida Časaitė*  | Mikas Sadauskas* | Justas Vaitekūnas* | Renata Gasparavičiūtė | Rita Meškienė | Izabelė Skikaitė |  Mantas Sakalauskas  |  Jevgenija Jakubovska  | Daiva Tauraitė | Rolandas Meškys

 

1| INTRODUC TION

In light of the growing importance of biocatalysis, strategies that provide improvements in screening of novel enzymes are of considerable interest. Among other enzymes, aldehyde dehydrogenases (ALDHs), especially exhibiting a broad substrate spectrum, are potential biocatalysts for biotechnology and are applicable in the de‐ toxification of aldehydes, generated during metabolism of different natural and xenobiotic compounds (Kotchoni, Kuhns, Ditzer, Kirch, & Bartels, 2006; Lyu et al., 2017; Singh et al., 2014).
Metagenomics, which  helps  to  circumvent  the  cultivation of bacteria and select genes directly from the environment, has become a powerful tool in search of new enzymes and meta‐ bolic pathways for the industrial biotechnology over the past decades (Allen, Moe, Rodbumrer, Gaarder, & Handelsman, 2009; Maruthamuthu, Jiménez, Stevens, & Elsas, 2016; Suenaga, Ohnuki, & Miyazaki, 2007; Varaljay et al., 2016). Many studies show that the function‐based screening or selection approaches permits an effective identification of different biocatalysts, such as lipases/ esterases (Reyes‐Duarte, Ferrer, & García‐Arellano, 2012), cel‐ lulases (Maruthamuthu et al., 2016), and oxygenases (Nagayama et al., 2015), from diverse environmental sources and microbial habitats. However, the common problem in the search for new enzymes is the absence of an appropriate screening system. Usually, the functional screening of  desired  activities is  based on chromogenic approach including the formation of blue indigo pigment, fluorogenic substrates, and/or sensors (Kennedy et al., 2011; Rüther, 1980; Seok et al., 2018; Shang, Chan, Wong, & Liao, 2018; Ye, Peng, Niu, Luo, & Zhang, 2018).

 

Notwithstanding that several chromogenic substrates such as indole, indole carboxylic acids, and indole‐3‐carboxaldehyde applicable for plate and other high‐throughput (HTP) assays have been developed and applied for screening various dioxygenases and broad substrate range monooxygenases (Celik, Speight, & Turner, 2005; Choi et al., 2003; Eaton & Chapman, 1995; Ensley et al., 1983; Furuya, Takahashi, Ishii, Kino, & Kirimura, 2004; McClay, Boss, Keresztes, & Steffan, 2005; O'Connor, Dobson, & Hartmans, 1997; Shi et al., 2013; Willetts, Joint, Gilbert, Trimble, & Mühling, 2012), a limited num‐ ber of HTP methods for detection of other oxidoreductases, for example, aldehyde dehydrogenases, have been elaborated (Chen et al., 2014; Oyobiki et al., 2014; Reisinger et al., 2006; Seok et al., 2018; Wexler, Bond, Richardson, & Johnston, 2005). Moreover, those approaches are too restricted for a special substrate, cannot be used in a plate format or require sophisticated equipment.

 

The aim of this study was to develop a novel platform for the functional screening of the enzymes, particularly ALDHs. First, we searched for indole‐3‐carboxylic acid (I3CA)‐degrading microor‐ ganisms and corresponding genes in metagenomes to determine whether any could transform I3CA to indigo. We have successfully identified Icm encoding gene, which was used for the creation of the screening method. By using the developed approach, we succeeded in a screening of diverse ALDHs with a broad substrate specificity. Furthermore, the auxiliary Icm enzyme was applied for screening of amidohydrolases using the amide of indole‐3‐carboxylic acid as a substrate. The Icm was active both in Gram‐negative and Gram‐pos‐ itive bacteria, and hence, the enzyme was suitable for a functional screening of enzymes in different hosts.

 

2| MATERIAL S AND METHODS 

2.1| Chemicals
Chemicals used in this study are listed in Table A1. Gel resins were purchased from GE Healthcare (Little Chalfont, UK). Restriction endonucleases and DNA polymerases were from Thermo Fisher Scientific (Vilnius, Lithuania). All reagents used in this study were of analytical grade.

2.2| Bacterial strains, plasmids and media
The bacterial strains and plasmids used in this study are listed in Table 1. Escherichia coli and Rhodococcus erythropolis SQ1 cells were routinely grown in Luria–Bertani (LB) medium at 16–37°C. The fol‐ lowing reagents were added to media as needed: IPTG, 40 μg/ml; ampicillin (Ap), 50 μg/ml; chloramphenicol (Cm), 20 µg/ml; kanamy‐ cin (Km) 50 μg/ml; tetracycline (Tc), 20 µg/ml; derivatives of I3CA, 1 mM.

2.3| General DNA manipulation
Plasmid preparation, restriction endonuclease digestion, DNA liga‐ tion, agarose gel electrophoresis, and other standard recombinant DNA techniques were carried out by standard methods (Sambrook, Fritsch, & Maniatis, 1989). DNA sequencing and primer synthesis were performed commercially at the Macrogen (the Netherlands). DNA sequences were analyzed with a BLAST program available at the National Center for Biotechnology Information web site (http:// blast.ncbi.nlm.nih.gov/Blast.cgi). Evolutionary analyzes were con‐ ducted in MEGA7 (Kumar, Stecher, & Tamura, 2016).

2.4| Screening of soil samples and gene cloning
About 1 g of soil samples were suspended in 1 ml 0.9% w/v NaCl solution, and 50 μl aliquots were spread on the agar plates supple‐ mented with 1 mM I3CA. The plates were incubated at 30°C for    48 hr and were subsequently visually inspected for colonies produc‐ ing the blue indigo pigment. Chromosomal DNA was isolated from the blue pigment producing bacteria, digested with the PstI restric‐ tion endonuclease and ligated in the pUC19 vector. Escherichia coli DH5α was used for screening of blue colonies on the plates supple‐ mented with 1 mM I3CA.
For the screening assay, the pKVIABam8 encoding the icm gene was digested with BamHI and PscI and subcloned to the BamHI and PagI restriction sites of pACYC184 vector and resulted plasmid was designated pACYC‐KVIA. For construction of  expression  vectors, icm gene was PCR‐amplified with primers KviaEcoR and KviaNde2F (Table 1) and pKviaBam8 as a DNA template. All PCR amplifications were performed using Phusion High‐Fidelity PCR Master Mix. PCR product was digested with NdeI/XhoI restriction endonucleases and ligated into pET‐21a(+) previously digested with the corresponding enzymes to obtain pET21‐KVIA. N‐terminal His6‐tag was added by subcloning of the icm gene into pET28c(+), resulting in pET28‐KVIA.

 

For expression in R. erythropolis SQ1, the digested PCR fragment  was ligated into pNitQC1 resulting in plasmid pNit‐KVIA. To obtain N‐terminal fusion of Icm with maltose‐binding protein (MBP), malE was amplified with primers MBP_F and MBP_R_Nco, digested with XbaI/NcoI, and ligated into pET28‐KVIA resulting in pET28‐MBP‐ KVIA. To obtain N‐terminal fusion with Strep‐Tag, Icm encoding gene was amplified with primers Kvia‐IBA3‐F and Kvia‐IBA3‐R, digested with Eco31I and ligated into Eco31I‐digested pASK‐IBA3, resulting in pASK‐IBA3‐KVIA. For cloning of aldehyde dehydrogenase Vmix gene, it was PCR‐amplified with primers VmixHindR and VmixNdeF (Table 1) and DNA from the metagenome clone Vmix as template. PCR product was digested with NdeI/HindIII restriction endonucleases and ligated into pNitRT1 previously digested with the corresponding enzymes  to obtain pNitRT‐Vmix. For construction of C‐terminal His6‐tagged amidohydrolase, MO13 gene was PCR‐amplified with primers am13F and am13R2 (Table 1) and pMO13 as DNA matrix. PCR product was digested with NdeI/XhoI restriction endonucleases and ligated into pET‐21a(+) previously digested with the corresponding enzymes to obtain pET21‐MO13. Electrocompetent cells were prepared as de‐ scribed previously (Nakashima & Tamura, 2004b; Stanislauskiene et al., 2012) and used for transformation.


2.5| Construction of the metagenomic library and
screening for enzymes
For the construction of environmental DNA libraries, surface soils (0–15 cm) from a different fields in district Vilnius (Lithuania) were collected. The environmental DNA was isolated from samples using ZR Soil Microbe DNA Kit (Zymo Research), partially digested with the endonucleases PstI or HindIII and ligated in the pUC19 vector. To analyze the number of clones in the library, quality of the library (a ratio of white/blue colonies), and the average insert length, E. coli DH5α cells were transformed with ligation mixtures and spread on LB agar plates supplemented with ampicillin, 1 mM IPTG, and 1 mM X‐gal. Eight white colonies‐forming clones from each library were chosen for plasmid DNA isolation and analysis of the length of the insert. For functional screening, E. coli DH5α cells harboring pACYC‐KVIA were transformed with the metagenomic libraries and plated on LB agar plates containing Ap, Cm, as needed and 1 mM solution of derivative I3CA. The plates were incubated at 37°C for 2 days and were subsequently screened for colonies that were able to produce the blue pigment indigo by visual detection. The posi‐ tive clones were subjected for DNA sequencing. The sequences ob‐ tained in the present study were deposited to the GenBank database under the accession numbers MG770119–MG770138, MG786188, MG786189, MG775032, MK284926, and MH476458. The full list is
given in Table A2.


2.6| Expression and purification of the recombinant proteins
For gene expression, E. coli BL21 (DE3) were transformed with pET21‐KVIA, pET28‐KVIA, pET28‐MBP‐KVIA, pASK‐IBA3‐KVIA,
and pET21‐MO13. The cells were grown at 30°C with rotary shak‐ ing until OD600 reached 0.8, and gene expression was induced with 0.05–0.5 mM IPTG for pET plasmids and 200 μg/L anhydrotetracy‐ cline for pASK‐IBA3 plasmid. The cells were incubated at 16–30°C for either 4 hr or overnight, collected by centrifugation, suspended in lysis buffer (50 mM Tris–HCl, pH 8.0, containing 150 mM of NaCl), disrupted by sonication and the lysates were used as total protein sample, while centrifugation‐clarified lysates (16,000 g for 10 min) were treated as a soluble fraction. The recombinant proteins were analyzed with 12% denaturing SDS–PAGE.
Purification through His6‐tag was carried out with nickel
HisTrap™ HP column according to the manufacturer's instructions. Strep‐tagged protein was purified with Strep‐Tactin XT Starter Kit according to manufacturer's protocol. MBP‐fused protein was puri‐ fied by MBP‐starch affinity chromatography using commercial grade cationic starch‐packed column essentially as described in (Duong‐  Ly & Gabelli, 2015). Protein quantification was performed by den‐ sitometry with GelAnalyzer software (Pavel & Vasile, 2012) using different concentrations (100, 250, and 500 μg/ml) of bovine serum albumin (ThermoFisher Scientific) as standard.

 

2.7| Bioconversion of aldehydes or carboxylic acids by whole cells
The E. coli or R. erythropolis SQ1 cells transformed with the appro‐ priate plasmids were grown aerobically in LB containing appropri‐ ated antibiotic at 30°C until optical density reached 0.8 (A600), then
0.5 mM of IPTG was added and cells were grown aerobically at 30°C for 12 hr. Cells were harvested by centrifugation, washed with 50 mM potassium phosphate buffer (pH 7.2), suspended in the same buffer and used as the whole cells. Then, 1 mM solutions of sub‐ strates were added, and bioconversion reactions were carried out at 30°C with shaking at 180 rpm for 1–24 hr. The conversion was fol‐ lowed by changes in UV absorption spectrum in 200–400 nm range or by HPLC/MS analysis, as described previously (Stankevičiūtė et al., 2016).

2.8| Monooxygenase activity assay
The monooxygenase activity was evaluated from the decrease of the absorbance at 340 nm due to oxidation of NADH or NADPH (ε340 = 6,220 M/cm), using spectrophotometer and was performed at room temperature. Simultaneously, reaction mixtures were in‐ cubated overnight at 30°C and inspected for the formation of blue precipitate. A total reaction volume of 1 ml contained 50 mM Tris– HCl, pH 7.5,  1 mM I3CA, different amounts (1–20 mM) of NADH    or NADPH and 50 μM of flavin (FAD, FMN or riboflavin). Reactions were initiated by adding 2.5 μg of the purified enzyme or 20 μl of the soluble fraction (approx. 10 μg of total protein).

2.9| Aldehyde dehydrogenase activity assay
For colorimetric assay, the cells were disrupted by sonication and the cell‐free extracts were used to analyze the ALDH activity as de‐ scribed in (Bianchi et al., 2017). In brief, the obtained supernatants were mixed with NAD+ (200 μM) and NADP+ (200 μM), nitroblue tetrazolium chloride (NBT, 200 μM), phenazine methosulfate (PMS, 20 μM), and an appropriate aldehyde (200 μM) in 50 mM Tris–HCl buffer, pH 8.0, at 30°C. A total reaction volume of 200 µl contained 50 µl of cell lysates (approx. 20 μg of total protein), and the reaction was followed spectrophotometrically (λ = 580 nm) in 96‐well micro‐ titer plates by monitoring the production of formazan dye after 1 and 3 hr.

2.10| Amidohydrolase activity assay
A total reaction volume of 0.5 ml contained 50 mM Tris–HCl, pH  8.5, and 1 mM of appropriate substrate. Reactions were initiated   by adding 2.5 μg of the purified enzyme. The progress of the reac‐ tion was followed by changes in UV absorption spectrum in 200– 600 nm range or by HPLC/MS analysis, as described previously (Stankevičiūtė et al., 2016).

2.11| Synthesis of N‐(3‐hydroxypropyl)‐indole‐3‐
carboxamide
A solution of indole‐3‐carboxylate (100 mg, 0.62 mmol) and N,N,N′,N′‐tetramethyl‐O‐(1H‐benzotriazol‐1‐yl)uronium hexafluo‐ rophosphate (HBTU, 235.3 mg, 0.62 mmol) in dimethylformamide (1.24 ml) was vigorously stirred for 30 min at room temperature. Then, 3‐amino‐1‐propanol (46.6 mg, 0.62 mmol) and triethylamine (86.5 µl, 0.62 mmol) were added to the reaction mixture and con‐ tinued stirring for additional 12 hr at the same temperature. The reaction mixture was diluted with water (10 ml) and extracted with ethyl acetate (3 × 15 ml). The organic phase was dried (Na2SO4) and the solvent evaporated under reduced pressure. The residue was purified by column chromatography (silica gel, chloroform/methanol mixture). Yield 65 mg (48%). Synthesized derivative was character‐ ized by NMR spectroscopy and HPLC/MS analysis. NMR spectra were recorded in DMSO‐d6 on a Bruker Ascend 400: 1H NMR– 400 MHz, 13C NMR–100 MHz. Chemical shifts (δ) are reported in ppm relative to the solvent resonance signal as an internal standard. MS (ESI+): m/z 219 [M+H]+, 217 [M−H]−.

1H NMR (DMSO‐d6): δ = 1.64–1.74 (m, 2H, CH2), 3.32 (dd, 2H, J = 12.8, 6.7 Hz, CH2), 3.48 (dd, 2H, J = 12.7, 6.4 Hz, CH2), 4.52 (bs, 1H, OH), 7.06–7.18 (m, 2H, CH), 7.42 (d, 1H, J = 7.8 Hz, CH), 7.87 (t, 1H, J = 5.5 Hz, NH), 7.99 (d, 1H, J = 2.9 Hz, CH), 8.13 (d, 1H, J = 7.7 Hz, CH), 11.52 (s, 1H, NH). 13C NMR (DMSO‐d6): δ = 33.31, 46.23, 59.15, 111.22, 112.22, 120.68, 121.42, 122.22, 126.52, 128.00, 136.57, 165.19.


3| RESULTS AND DISCUSSION

3.1| Cloning and identification of indole‐3‐carboxylate monooxygenase
To screen enzymes displaying an indigo‐forming activity in the presence of I3CA, two approaches were used. Initially, several blue colonies‐forming bacteria were screened using soil  samples  and the agar plates supplemented with I3CA. One of these isolates, KVIA, was chosen for further studies. The analysis of the 16S rRNA gene sequence (GenBank accession No. MG775032) revealed that the bacteria belonged to the Bosea genus. The genomic library of Bosea sp. KVIA was constructed, and the positive clone harboring the plasmid pKVIABam8 was identified based on the ability to form blue colonies on the plates supplemented with I3CA. The nucleotide sequence analysis showed one 1,242 bp long ORF in the insert. The ORF encoded a 414 aa long protein, which was 98% identical to the hypothetical flavin‐dependent oxidoreductase from Bosea sp. WAO (GenBank accession No. WP_066468592). Two additional blue colo‐ nies‐forming clones were selected from the metagenomic libraries on I3CA agar plates. Both hits, named MILC and NVS, encoded the proteins, which shared 95.7% and 62.7% identity to the protein en‐ coded by the pKVIABam8 plasmid, respectively. According to the sequence analysis, all three screened proteins (KVIA, MILC and NVS clones) belonged to the group A of flavin monooxygenases, which depend on NAD(P)H as external electron donor and contain a glu‐ tathione reductase (GR‐2) type Rossmann fold (GXGXXG) for FAD binding. Moreover, several conserved motifs such as DGX5R, and GDAX10GX6DX3L characteristic for monooxygenases were identi‐  fied (Huijbers, Montersino, Westphal, Tischler, & Berkel, 2014). Some dioxygenases such as cumate and m‐toluate dioxygenases convert indole‐2‐carboxylic acid and I3CA to indigo. The dioxygenases in‐ corporate two atoms of molecular oxygen, leading to the formation of 2,3‐dihydroxyindoline‐3‐carboxylate. Subsequent reactions are spontaneous and lead to the mixture of indigo, isatin, and indirubin.


Moreover, those enzymes are also active toward indole (Eaton & Chapman, 1995). In contrast, the enzymes encoded by the KVIA, MILC, and NVS clones were unrelated to any known dioxygenase and showed the highest sequence similarity to the experimentally characterized monooxygenases such as 5‐methylphenazine‐1‐car‐ boxylate 1‐monooxygenase from Pseudomonas aeruginosa PAO1 and 3‐hydroxybenzoate‐6‐hydroxylase from Pseudomonas alcaligenes or Klebsiella oxytoca. Moreover, the identified enzymes were not ac‐  tive toward indole since the clones did not form colored colonies in the presence of this substrate. In addition, no substrate consumption was observed (HPLC‐MS analysis) when nicotinic, 2‐ and 4‐picolinic, 5‐hydroxypiperazine‐2‐carboxylic, salicylic acid, indoline‐2‐carbox‐ ylic, indole‐2‐carboxylic, indole‐4‐carboxylic, indole‐5‐carboxylic, indole‐6‐carboxylic, and indole‐7‐carboxylic were used as substrates for indole‐3‐carboxylate monooxygenase (Icm). We also tested this enzyme with 5‐nitroindole‐3‐carboxylic, 7‐methylindole‐3‐carbox‐ ylic, 1‐methylindole‐3‐carboxylic and as well as indole‐3‐carboxal‐ dehyde, indole‐3‐carbonitrile or methyl ester of indole‐3‐carboxylic acid for formation of the blue colonies on plates. No color changes were observed using these derivatives of indole‐3‐carboxylic acid. Based on sequence analysis and substrate specificity, we designated the identified enzyme as an indole‐3‐carboxylate monooxygenase (Icm). We proposed that Icm performed an oxidative decarboxy‐ lation reaction like other known flavin‐dependent monooxyge‐  nases that catalyze the decarboxylative hydroxylation of aromatic carboxylic acids (Figure 1b) such as the salicylate monooxygenase from Pseudomonas putida (Uemura et al., 2016), 6‐hydroxynicotinic acid 3‐monooxygenases NicC from P. putida and Bordetella bron- chiseptica (Hicks et al., 2016), 5‐methyl phenazine‐1‐carboxylate‐1‐ monooxygenase PhzS from P. aeruginosa (Mavrodi et al., 2001), 4‐hydroxybenzoate 1‐hydroxylase from Candida parapsilosis (Van Berkel, Eppink, Middelhoven, Vervorrt, & Rietjens, 1994), 4‐amin‐ obenzoate monooxygenase from Agaricus bisporus (Tsuji, Ogawa, Bando, & Sasaoka, 1986). The relationship between similar enzymes is shown in the phylogenetic tree (Figure 1a).

3.2| Expression, protein purification, and characterization of the Icm
To characterize Icm in more detail, the gene encoding Icm was cloned to several expression plasmids, fusing it to His6‐Tag, Strep‐Tag, maltose‐binding protein (MBP) or glutathione S‐trans‐ ferase (GST) or without any tag for protein expression. Also, the plasmid (pNitQC1‐KVIA) for protein expression in R. erythropolis SQ1 cells was created. Only the N‐terminal fusion of Icm with MBP (His6‐MBP‐His6‐Icm) resulted in partially soluble protein (Table A3). Conventional optimization strategies (variation of temperature, inductor concentration, cell density, expression host, buffer composition, etc.) did not result in significant im‐ provement of protein solubility. Once outside the cell, the activ‐ ity of Icm diminished. No in vitro activity was detected with the purified His6‐MBP‐His6‐Icm by using different flavin  cofactors and following the oxidation of either NADH or NADPH. Similarly, neither substrate consumption nor any intermediate products were detected by HPLC/MS, and no blue precipitate was formed in these in vitro reactions.

 

Since the active purified protein could not be obtained, further work was carried out using the whole cells of recombinant E. coli or R. erythropolis SQ1 bacteria. It was found that I3CA was consumed by all Icm derivatives at a similar rate (Figure A1). The amount of a blue precipitate formed during the bioconversion of I3CA cor‐ responded to the consumption of this substrate. Meanwhile, no pigment appeared in the control reactions, in which the cells trans‐ formed with blank vectors were used. This indicates that Icm is active inside the cell and is involved in the conversion of I3CA to indigo blue.


3.3| Application of Icm as an auxiliary enzyme for functional screening of aldehyde dehydrogenases
Despite the fact that Icm activity was not detected in vitro, E. coli cells harboring the icm gene readily produced a blue indigo dye on the agar plates supplemented with I3CA. This property was further exploited to create a system for a functional screening of metagen‐ omic libraries. The idea was to use the appropriate substrate, for ex‐ ample indole‐3‐carboxaldehyde, which would be converted to I3CA by the target enzyme, in this case ALDH. Then, Icm as an auxiliary enzyme would oxidize I3CA into indigo; hence, the colored E. coli colonies would indicate the presence of the active ALDH (Figure 2). To test such screening platform, the icm gene was subcloned into the pACYC184 vector, compatible with the pUC19, which was used for creation of metagenomic DNA libraries. The E. coli DH5α cells trans‐ formed with pACYC‐KVIA produced blue colonies on the agar plates supplemented with I3CA (0.01 mM of I3CA in the medium was suf‐ ficient for the formation of blue pigment (Figure 1d), but only white colonies were observed when indole‐3‐carboxaldehyde was used as a substrate. Therefore, this strain was further used for screening of metagenomic libraries.

 

Twenty‐one metagenomic libraries were created using the pUC19 plasmid and DNA isolated from soil. Each library contained clones with inserts of ~3–15 kb average size, yielding approximately 0.5 Gb of total cloned genomic DNA per library. In order to screen for ALDH activity, about 30,000 clones per library were spread on LB agar supplemented with indole‐3‐carboxaldehyde. In this way, 52 indigo‐forming clones were identified. The clones producing indigo without the presence of Icm (the false positives, i.e., most of such clones encoded Baeyer–Villiger monooxygenases, data not shown) as well as redundant clones were omitted resulting in 20 unique hits harboring the distinct genomic fragments. The sequence analysis of the screened ALDH‐positive clones revealed the presence of genes encoding the proteins that were 73%–99% identical to the known sequences in the NCBI databank and homologous to ALDHs (19 clones), and molybdopterin xanthine dehydrogenase (one clone; see Table A2). Thus, the proposed functional screening approach was suitable for identification of hits expressing ALDHs (Table 2). To gain insight into the phylogenetic relationship of all selected enzymes, the phylogenetic tree was constructed (Figure 3). As revealed by com‐ parison between UniProtKB/SwissProt sequences, nine ALDHs, that is, pDON4, pALDGA1, JU61, pALD442, pER2AH2, Vmix, pALDJU6, pALDBS21, and pALD458 were closest to vanillin dehydrogenase, pALDMO9 was related to B. subtilis vanillin dehydrogenase. pEMMO, pALDMO11, and UraGR were related to NAD(+)‐dependent benzal‐ dehyde dehydrogenase and pALDBSal to NAD(P)‐dependent benz‐ aldehyde dehydrogenase. The sequences of clones pRG1, pEGA1, and  pALDSV3  were  closest  to  betaine  aldehyde dehydrogenase.


Also, two 4‐hydroxybenzaldehyde dehydrogenase‐like enzymes were selected (pER2AH, pRG2).
To analyze a substrate specificity of the screened enzymes, the bioconversion of substrates by whole cells was monitored by UV‐Vis spectrophotometer and products of the reaction were confirmed by HPLC‐MS analysis (Table 3). For some substrates, the colorimetric assay based on the formation of formazan by the cell‐free extracts was applied (Table 4). Thirteen derivatives of indole‐3‐carboxyalde‐ hyde were tested. The most preferred substrates among the tested ones were 5‐bromindole‐3‐carboxaldehyde, 6‐benzyloxyindole‐3‐ carboxaldehyde, and 1H‐benzo[g]indole‐3‐carboxaldehyde, which were oxidized by 18 ALDHs (Table 3). Only one strain (pALDR177) could oxidize 2‐phenylindole‐3‐carboxaldehyde. The whole cells  with an empty vector (E. coli DH5α/pUC19) did not show any activity on the tested substrates, confirming that the ALDHs were encoded by the metagenomic inserts. Even though among aldehydes without indole ring, the favorable substrate was 3‐hydroxybenzaldehyde, which was oxidized by 19 clones, the hits showed very different sub‐ strate specificity (Table 4), and hence, the offered screening platform allowed the identification of ALDHs both of different structures and catalytic properties.

 

To  test whether the screening of ALDHs could be carried out    in another bacterial host, one ALDH gene was subcloned to the pNitRT1 plasmid for expression in R. erythropolis SQ1. It turned out, that the cells transformed with pNitRT1‐Vmix and pNitQC1‐KVIA could produce indigo dye on the plates supplemented with indole‐3‐ carboxaldehyde (Figure 4). Considering the fact that not all enzymes encoded in the metagenome can be active in E. coli cells, the Gram‐ positive host such as Rhodococcus sp. would be a good additional alternative for a functional screening of ALDHs, thereby expanding the variety of the selectable enzymes.

 

To test further the substrate specificity of Icm and to enlarge the list of  compounds applicable for  the screening purposes,   we have chosen E. coli cells transformed with pACYC‐KVIA and pALDR177 plasmids. According to the activity tests, the ALDR177 clone was able to oxidize the widest spectrum of derivatives of indole‐3‐carboxaldehydes to the corresponding carboxylic acids. Transformants were spread on the agar plates  supplemented with various indole  ring  containing  aldehydes  and  incubated  at 30°C for 48 hr. Colonies remained uncolored on 4‐nitroin‐ dole‐3‐carboxaldehyde, 4‐benzyloxyindole‐3‐carboxaldehyde, 5‐benzyloxyindole‐3‐carboxaldehyde, 6‐benzyloxyindole‐3‐car‐ boxaldehyde, benzo[b]thiophene‐3‐carboxaldehyde, however, pigmented colonies appeared on media supplemented with 5‐ methylindole‐3‐carboxaldehyde, benzo[g]indole‐3‐carboxalde‐ hyde, 1,6,7,8‐tetrahydrocyclopenta[g]indole‐3‐carboxaldehyde, 5‐bromoindole‐3‐carboxaldehyde (Figure A2), indicating that the corresponding carboxylic acids served as substrates for Icm. The consumption of aldehydes was confirmed by HPLC‐MS. It could  be concluded that those aldehydes might be applicable for a more selective screening of ALDHs.


3.4 | Screening of amidohydrolases
Encouraged with the successful screening of ALDHs, we tested whether icm gene‐based approach could be extended for the functional screening of other enzymes. N‐(3‐hydroxypropyl)‐in‐ dole‐3‐carboxamide was synthesized and used as a substrate for amidohydrolases. One positive clone forming a blue colony was iden‐ tified after testing two metagenomic DNA libraries (approx. 20,000 clones). The plasmid pMO13 isolated from this hit contained a DNA fragment encoding a 489 aa long protein, which was 90% identical to hypothetical amidase (WP_010677135) and shared 41% identity to indoleacetamide hydrolase (WP_011083078). Subsequently, MO13 amidase was cloned into pET‐21a(+) vector, heterologously expressed in E. coli BL21(DE3), and purified as the C‐His6‐tagged recombinant protein. The analysis of the substrate specificity of MO13 amido‐ hydrolase showed that in addition to N‐(3‐hydroxypropyl)‐indole‐3‐ carboxamide, the enzyme could hydrolyze indole‐5‐carboxamide, nicotinamide, hippuric acid,  glycyl‐L‐leucine,  and  L‐valyl‐L‐valine to corresponding carboxylic acids. MO13 was also active toward L‐leucin‐p‐nitroanilide, 4‐nitroacetanilide, and 4‐nitrobenzanilide. Moreover, this amidase was able to regioselectively deprotect lysine in Nε position when Nα,Nε‐di‐Z‐L‐lysine or Nα‐Boc‐Nε‐Z‐L‐lysine was used as substrates.


4| CONCLUSIONS

In this study, we have successfully identified a monooxygenase (Icm) active toward indole‐3‐carboxylic acid. The indigo formation due to activity of Icm allowed the development of a simple system for functional screening of enzymes from the metagenomic librar‐ ies. We showed that different enzymes, for example, ALDHs or amidohydrolases could be identified depending on the used sub‐ strate. Moreover, the system might be easily extended for screen‐ ing other activities as shown in Figure 2. The only requirement is that the product of enzymatic reaction would be indole‐3‐carboxylic acid (with or without substituents in the indole ring), which could be a substrate for an auxiliary enzyme Icm. It should be noted that Icm was active not only in E. coli but also in R. erythropolis SQ1 cells that could open additional possibilities to use the different bacterial hosts for the functional screening.


ACKNOWLEDG EMENT

We are grateful to Kristė Šalkauskienė for technical assistance.


CONFLIC T OF INTEREST

The authors declare no conflict of interests.

ANGENE is pledged to providing quality specialty chemicals for use in research and development and commercial manufacturing:

CAS No. 106015-33-2

7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-3-(fluoromethyl)-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-

Catalog No.:AG0008P6 MDL No.:

MF:C18H19F2N3O4 MW:379.3580

CAS No. 113446-74-5

Benzene, [(2-ethenylhexyl)oxy]-

Catalog No.:AG0008N4 MDL No.:

MF:C14H20O MW:204.3080

CAS No. 113446-75-6

Propanedinitrile, 2,2',2'',2'''-(1,4,5,8-anthracenetetraylidene)tetrakis-

Catalog No.:AG0008N3 MDL No.:

MF:C26H6N8 MW:430.3794

CAS No. 113446-76-7

Anthracene, 1,4,5,8-tetrabromo-1,2,3,4,5,6,7,8-octahydro-

Catalog No.:AG0008N2 MDL No.:

MF:C14H14Br4 MW:501.8770

CAS No. 113447-02-2

2H-Indol-2-one, 1,3-dihydro-1-(methylamino)-

Catalog No.:AG0008N1 MDL No.:

MF:C9H10N2O MW:162.1885

CAS No. 113447-04-4

5-Pyrimidinecarbonitrile, 4-amino-2-(4-chlorophenoxy)-

Catalog No.:AG0008N0 MDL No.:MFCD00067829

MF:C11H7ClN4O MW:246.6525

CAS No. 113447-19-1

1,3-Cyclobutanedione, 2,4-didodecyl-

Catalog No.:AG0008MZ MDL No.:

MF:C28H52O2 MW:420.7113

CAS No. 113447-24-8

Glycine, N-(2-hydroxypropyl)-

Catalog No.:AG0008MY MDL No.:

MF:C5H11NO3 MW:133.1457

CAS No. 113447-58-8

Phenol, 4,4'-[1-(4-hydroxyphenyl)ethylidene]bis[2,6-dimethyl-

Catalog No.:AG0008MX MDL No.:

MF:C24H26O3 MW:362.4614

CAS No. 113447-59-9

Oxirane, 2-[(3,5-dibromo-2,4,6-trimethylphenoxy)methyl]-

Catalog No.:AG0008MW MDL No.:

MF:C12H14Br2O2 MW:350.0464

CAS No. 113447-61-3

7-Thiabicyclo[4.1.0]heptane, 1-methyl-4-(2-methyl-2-thiiranyl)-

Catalog No.:AG0008MV MDL No.:

MF:C10H16S2 MW:200.3640

CAS No. 113447-89-5

1,4-Benzenediamine, N1-(4-aminophenyl)-N1-[(4-aminophenyl)methyl]-

Catalog No.:AG0008MU MDL No.:

MF:C19H20N4 MW:304.3889

CAS No. 113449-12-0

Ethanediamide, N1-(2-methoxyphenyl)-N2-(2-methylphenyl)-

Catalog No.:AG0008MT MDL No.:

MF:C16H16N2O3 MW:284.3098

CAS No. 113449-19-7

2H-Imidazole, 2-(2H-imidazol-2-ylidene)-

Catalog No.:AG0008MS MDL No.:

MF:C6H4N4 MW:132.1228

CAS No. 113449-25-5

Telluronium, dibutyl[2-[(2-methylpropyl)amino]-2-oxoethyl]-, bromide (1:1)

Catalog No.:AG0008MR MDL No.:

MF:C14H30BrNOTe MW:435.8981

CAS No. 113449-31-3

Methanone, [1,1'-biphenyl]-2-yl(4-methylphenyl)-

Catalog No.:AG0008MQ MDL No.:

MF:C20H16O MW:272.3404

CAS No. 113449-74-4

1(2H)-Naphthalenone, 2-diazo-5-(sulfooxy)-

Catalog No.:AG0008MP MDL No.:

MF:C10H6N2O5S MW:266.2300

CAS No. 113450-09-2

4,5-Oxazolidinedione, 2-(phenylmethylene)-, (Z)- (9CI)

Catalog No.:AG0008MO MDL No.:

MF:C10H7NO3 MW:189.1675

CAS No. 113450-81-0

1,3,5-Benzenetrimethanethiol, 2-fluoro-

Catalog No.:AG0008MN MDL No.:

MF:C9H11FS3 MW:234.3770

CAS No. 113450-84-3

2-Propen-1-one, 1-(2,3,4,5,6-pentamethylphenyl)-

Catalog No.:AG0008MM MDL No.:

MF:C14H18O MW:202.2921

CAS No. 113450-87-6

2-Butenoic acid, 4-oxo-4-(2,3,4,5,6-pentamethylphenyl)-, ethyl ester

Catalog No.:AG0008ML MDL No.:

MF:C17H22O3 MW:274.3548

CAS No. 113450-88-7

2-Propen-1-one, 1-(pentamethylphenyl)-3-phenyl- (9CI)

Catalog No.:AG0008MK MDL No.:

MF:C20H22O MW:278.3881

CAS No. 113451-12-0

1-Propanone, 3-(4-nitrophenyl)-1-phenyl-3-(phenylamino)-

Catalog No.:AG0008MJ MDL No.:

MF:C21H18N2O3 MW:346.3792

CAS No. 113451-20-0

Naphthalene, 1-[bis(phenylthio)methyl]-

Catalog No.:AG0008NS MDL No.:

MF:C23H18S2 MW:358.5190

CAS No. 113451-48-2

Butanedioic acid, methyl-, monomethyl ester (9CI)

Catalog No.:AG0008NR MDL No.:

MF:C6H9O4- MW:145.1333

CAS No. 113451-52-8

1-Pyrrolidinecarboxylic acid, 3-azido-, 1,1-dimethylethyl ester

Catalog No.:AG0008NQ MDL No.:MFCD20257710

MF:C9H16N4O2 MW:212.2489

CAS No. 113451-60-8

Butanoic acid, 2-hydroxy-, trimethylsilyl ester

Catalog No.:AG0008NP MDL No.:

MF:C7H16O3Si MW:176.2856

CAS No. 113451-64-2

Quinolinium, 1-hexadecyl-5-hydroxy-

Catalog No.:AG0008NO MDL No.:

MF:C25H40NO+ MW:370.5912

CAS No. 113451-98-2

2-Furancarboxylic acid, 5,5'-[1,4-phenylenebis(oxy)]bis-, dimethyl ester (9CI)

Catalog No.:AG0008NN MDL No.:

MF:C18H14O8 MW:358.2990

CAS No. 113452-74-7

2-Oxazolidinone, 4-(2-furanyl)-, (4S)-

Catalog No.:AG0008NM MDL No.:

MF:C7H7NO3 MW:153.1354

CAS No. 113452-76-9

Benzoic acid, 2-hydroxy-3-iodo-6-methoxy-

Catalog No.:AG0008NL MDL No.:

MF:C8H7IO4 MW:294.0433

CAS No. 113452-82-7

Benzene, 1-(2-chloro-1-methylethyl)-2-iodo-

Catalog No.:AG0008NK MDL No.:

MF:C9H10ClI MW:280.5332

CAS No. 1134524-25-6

Cyclopropanamine, 1-(4-fluorophenyl)-, hydrochloride (1:1)

Catalog No.:AG0008N7 MDL No.:MFCD07995728

MF:C9H11ClFN MW:187.6417

CAS No. 1134529-25-1

Benzonitrile, 2-(aminomethyl)-, hydrochloride (1:1)

Catalog No.:AG0008N6 MDL No.:MFCD06797973

MF:C8H9ClN2 MW:168.6235

CAS No. 113453-27-3

Silane, (1,1-dimethylethyl)[[(2S)-5-iodo-2-methylpentyl]oxy]dimethyl-

Catalog No.:AG0008NJ MDL No.:

MF:C12H27IOSi MW:342.3321

CAS No. 1134541-61-9

Benzenemethanamine, 4-amino-2-fluoro-N,N-dimethyl-

Catalog No.:AG0008N5 MDL No.:MFCD20411317

MF:C9H13FN2 MW:168.2113

CAS No. 113455-70-2

4-Piperidineacetic acid, 5-ethyl-2-oxo-

Catalog No.:AG0008NI MDL No.:

MF:C9H15NO3 MW:185.2203

CAS No. 113456-94-3

Methanone, (2-chloro-5-nitrophenyl)(2,4-dimethylphenyl)-

Catalog No.:AG0008NH MDL No.:MFCD03140317

MF:C15H12ClNO3 MW:289.7137

CAS No. 113456-95-4

Methanone, (2-chloro-5-nitrophenyl)(3,4-dichlorophenyl)-

Catalog No.:AG0008NG MDL No.:

MF:C13H6Cl3NO3 MW:330.5506

CAS No. 113457-10-6

Benzamide, 4-[(2-chlorophenyl)methoxy]-3-methoxy-N-4-pyridinyl-

Catalog No.:AG0008NF MDL No.:

MF:C20H17ClN2O3 MW:368.8136

CAS No. 113457-27-5

Benzoic acid, 4-[(2-chlorophenyl)methoxy]-3-methoxy-

Catalog No.:AG0008NE MDL No.:MFCD02628391

MF:C15H13ClO4 MW:292.7143

CAS No. 113457-95-7

1,3-Propanediol, 2-[2-(1,3-dioxolan-2-yl)ethyl]-

Catalog No.:AG0008ND MDL No.:

MF:C8H16O4 MW:176.2102

CAS No. 113458-72-3

Heptanenitrile, 2,2,4-trichloro-5-oxo-

Catalog No.:AG0008NC MDL No.:

MF:C7H8Cl3NO MW:228.5035

CAS No. 113458-95-0

2-Naphthalenecarboxylic acid, 6,7-dihydroxy-

Catalog No.:AG0008NB MDL No.:

MF:C11H8O4 MW:204.1788

CAS No. 113458-97-2

2-Naphthalenesulfonic acid, 4-chloro-6,7-dihydroxy-

Catalog No.:AG0008NA MDL No.:

MF:C10H7ClO5S MW:274.6776

CAS No. 113458-98-3

1H-Azepine, 1-hexadecylhexahydro-

Catalog No.:AG0008N9 MDL No.:

MF:C22H45N MW:323.5994

CAS No. 113458-99-4

1H-Azepine, 1-dodecylhexahydro-3,3,5-trimethyl-

Catalog No.:AG0008N8 MDL No.:

MF:C21H43N MW:309.5728

CAS No. 113459-05-5

Benzoic acid, 4-(methylsulfonyl)-, (2-methoxybenzoyl)azanyl ester

Catalog No.:AG0008OH MDL No.:

MF:C16H15NO6S MW:349.3584

CAS No. 113459-54-4

2-Butenedioic acid, 2-methyl-, 4-ethyl ester, (2Z)-

Catalog No.:AG0008OG MDL No.:

MF:C7H9O4- MW:157.1440

CAS No. 113459-59-9

Cyclopentanone, 3-methyl-2-(phenylsulfonyl)-

Catalog No.:AG0008OF MDL No.:

MF:C12H14O3S MW:238.3028

CAS No. 113459-61-3

Cyclopentanone, 4,4-dimethyl-2-(phenylsulfonyl)-

Catalog No.:AG0008OE MDL No.:

MF:C13H16O3S MW:252.3293

CAS No. 113459-88-4

Benzene, 1,1'-(1,2-ethenediyl)bis[2,4,5-trimethyl-

Catalog No.:AG0008OD MDL No.:

MF:C20H24 MW:264.4046

CAS No. 113459-91-9

Benzamide, 3-nitro-N-[(phenylamino)carbonyl]-N-(phenylmethoxy)-

Catalog No.:AG0008OC MDL No.:

MF:C21H17N3O5 MW:391.3768

CAS No. 113459-98-6

Benzamide, N-(cyclohexyloxy)-4-nitro-N-[(phenylamino)carbonyl]-

Catalog No.:AG0008OB MDL No.:

MF:C20H21N3O5 MW:383.3978

CAS No. 1134594-76-5

2-Quinolinecarboxylic acid, 8-amino-1,2,3,4-tetrahydro-, ethyl ester

Catalog No.:AG0008NX MDL No.:

MF:C12H16N2O2 MW:220.2676

CAS No. 113460-09-6

5H-Benzo[b]phosphindolium, 5,5-dibutyl-, iodide (1:1)

Catalog No.:AG0008OA MDL No.:

MF:C20H26IP MW:424.2987

CAS No. 113460-10-9

5H-Benzo[b]phosphindolium, 5,5-diethyl-, iodide (1:1)

Catalog No.:AG0008O9 MDL No.:

MF:C16H18IP MW:368.1924

CAS No. 113460-59-6

Benzamide, 4-chloro-N-(2-propen-1-yloxy)-

Catalog No.:AG0008O8 MDL No.:

MF:C10H10ClNO2 MW:211.6449

CAS No. 1134600-62-6

4-Thiazolecarboxylic acid, 2-[(4-methoxyphenyl)amino]-, hydrobromide (1:1)

Catalog No.:AG0008NW MDL No.:MFCD09027184

MF:C11H11BrN2O3S MW:331.1856

CAS No. 1134603-63-6

2H-Thiopyran-4-acetic acid, α-aminotetrahydro-, methyl ester

Catalog No.:AG0008NV MDL No.:MFCD04115502

MF:C8H15NO2S MW:189.2752

CAS No. 113461-28-2

9,10-Anthracenedione, 1,3,5,7-tetrakis[(4-butylphenyl)thio]-

Catalog No.:AG0008O7 MDL No.:

MF:C54H56O2S4 MW:865.2812

CAS No. 113461-65-7

1,4-Naphthalenedione, 6-(acetyloxy)-2-chloro-8-hydroxy-

Catalog No.:AG0008O6 MDL No.:

MF:C12H7ClO5 MW:266.6340

CAS No. 113461-97-5

Acetic acid, 2-[(3-formyl-1H-indol-4-yl)thio]-, methyl ester

Catalog No.:AG0008O5 MDL No.:

MF:C12H11NO3S MW:249.2856

CAS No. 1134611-60-1

Imidazo[2,1-b]thiazole, 2-bromo-5,6-dihydro-3-phenyl-, hydrobromide (1:1)

Catalog No.:AG0008NU MDL No.:MFCD09817449

MF:C11H10Br2N2S MW:362.0835

CAS No. 1134614-73-5

3-Pyridinecarbonitrile, 2-chloro-6-ethynyl-5-fluoro-

Catalog No.:AG0008NT MDL No.:

MF:C8H2ClFN2 MW:180.5663

CAS No. 113463-18-6

3-Pyrazolidinone, 5-(4-methoxyphenyl)-1-phenyl-

Catalog No.:AG0008O4 MDL No.:

MF:C16H16N2O2 MW:268.3104

CAS No. 113463-19-7

3-Pyrazolidinone, 5-(4-methoxyphenyl)-1-(4-methylphenyl)-

Catalog No.:AG0008O3 MDL No.:

MF:C17H18N2O2 MW:282.3370

CAS No. 113464-46-3

Pyridine, 2-(1-octyl-1H-imidazol-2-yl)-

Catalog No.:AG0008O2 MDL No.:

MF:C16H23N3 MW:257.3739

CAS No. 113464-69-0

2,5-Cyclohexadien-1-one, 4-(9-acridinylamino)-3-methoxy-

Catalog No.:AG0008O1 MDL No.:

MF:C20H16N2O2 MW:316.3532

CAS No. 113464-95-2

Phenol, 2-methoxy-4-[2-(5-methyl-1H-pyrazol-3-yl)ethyl]-

Catalog No.:AG0008O0 MDL No.:

MF:C13H16N2O2 MW:232.2783

CAS No. 113465-94-4

1H-Pyrazole-3-acetic acid, 5-methyl-, methyl ester

Catalog No.:AG0008NZ MDL No.:

MF:C7H10N2O2 MW:154.1665

CAS No. 113466-23-2

4H,5H-Thiopyrano[3,2-c][1]benzopyran-4-one, 2,3-dihydro-9-methyl-

Catalog No.:AG0008NY MDL No.:

MF:C13H12O2S MW:232.2982

CAS No. 113466-65-2

1H-Imidazole-4-acetonitrile, 2,5-diiodo-

Catalog No.:AG0008P5 MDL No.:

MF:C5H3I2N3 MW:358.9064

CAS No. 113466-68-5

2-Oxiranecarboxylic acid, 2-chloro-3-hexyl-, ethyl ester

Catalog No.:AG0008P4 MDL No.:

MF:C11H19ClO3 MW:234.7198

CAS No. 113466-82-3

2-Pyrrolidinone, 5-(azidomethyl)-

Catalog No.:AG0008P3 MDL No.:MFCD24452749

MF:C5H8N4O MW:140.1432

CAS No. 113467-48-4

Dodecanamide, N-[2-[[(2S)-2-amino-3-methyl-1-oxobutyl]amino]-2-deoxy-β-D-glucopyranosyl]-N-octadecyl-

Catalog No.:AG0008P2 MDL No.:

MF:C41H81N3O6 MW:712.0983

CAS No. 113467-80-4

Propanamide, N-[2-(4,4-dimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]-

Catalog No.:AG0008P1 MDL No.:

MF:C10H17N3O3 MW:227.2603

CAS No. 113467-95-1

Benzoic acid, 5-iodo-2-[(1-oxododecyl)oxy]-

Catalog No.:AG0008P0 MDL No.:

MF:C19H27IO4 MW:446.3197

CAS No. 113467-97-3

2-Butenoic acid, 4-(cyclohexylamino)-4-oxo-, (E)- (9CI)

Catalog No.:AG0008OZ MDL No.:MFCD00086001

MF:C10H15NO3 MW:197.2310

CAS No. 113468-00-1

Dodecanoic acid, 4-iodophenyl ester

Catalog No.:AG0008OY MDL No.:

MF:C18H27IO2 MW:402.3102

CAS No. 113468-01-2

Benzenesulfonic acid, 3-(sulfoamino)-

Catalog No.:AG0008OX MDL No.:

MF:C6H7NO6S2 MW:253.2529

CAS No. 113468-54-5

Benzene, 1-chloro-2-[1,2,2,2-tetrachloro-1-(4-chlorophenyl)ethyl]-

Catalog No.:AG0008OW MDL No.:

MF:C14H8Cl6 MW:388.9313

CAS No. 1134683-51-4

Cyclopropanamine, 1-(3-methylphenyl)-, hydrochloride (1:1)

Catalog No.:AG0008OM MDL No.:MFCD07995724

MF:C10H14ClN MW:183.6779

CAS No. 113469-03-7

Naphthalene, 1,4-bis(ethylthio)-

Catalog No.:AG0008OV MDL No.:

MF:C14H16S2 MW:248.4068

CAS No. 1134691-04-5

Benzenepropanoic acid, 4-(dimethylamino)-, hydrochloride (1:1)

Catalog No.:AG0008OL MDL No.:MFCD06797873

MF:C11H16ClNO2 MW:229.7032

CAS No. 1134699-45-8

Cyclopropanamine, 1-(2-chlorophenyl)-, hydrochloride (1:1)

Catalog No.:AG0008OK MDL No.:MFCD07995726

MF:C9H11Cl2N MW:204.0963

CAS No. 113470-40-9

Methanehydrazonothioic acid, N-methyl-N-phenyl-, ethyl ester

Catalog No.:AG0008OU MDL No.:

MF:C10H14N2S MW:194.2966

CAS No. 113470-41-0

Formaldehyde, 1-(ethylsulfinyl)-, 2-methyl-2-phenylhydrazone

Catalog No.:AG0008OT MDL No.:

MF:C10H14N2OS MW:210.2960

CAS No. 113470-82-9

Urea, N-methyl-N-(phenylmethyl)-N'-(2,3,4,5-tetrachlorophenyl)-

Catalog No.:AG0008OS MDL No.:

MF:C15H12Cl4N2O MW:378.0806

CAS No. 1134701-31-7

Cyclopropanamine, 1-(2-methylphenyl)-, hydrochloride (1:1)

Catalog No.:AG0008OJ MDL No.:MFCD07995723

MF:C10H14ClN MW:183.6779

CAS No. 113471-08-2

3-Thiophenecarbonyl chloride, 5-chloro-

Catalog No.:AG0008OR MDL No.:

MF:C5H2Cl2OS MW:181.0398

CAS No. 1134724-15-4

1H-Indol-6-amine, 4-chloro-, hydrochloride (1:1)

Catalog No.:AG0008OI MDL No.:

MF:C8H8Cl2N2 MW:203.0685

CAS No. 113473-30-6

3-Pyrrolidinecarboxylic acid, 3-amino-, (3S)-

Catalog No.:AG0008OQ MDL No.:MFCD09971714

MF:C5H10N2O2 MW:130.1451

CAS No. 113473-87-3

7-Oxabicyclo[4.1.0]heptan-2-ol, 4,4,6-trimethyl-

Catalog No.:AG0008OP MDL No.:

MF:C9H16O2 MW:156.2221

CAS No. 113474-25-2

1,3-Cyclohexanedicarboxylic acid, 5-hydroxy-, 1,3-dimethyl ester

Catalog No.:AG0008OO MDL No.:MFCD22741888

MF:C10H16O5 MW:216.2310

CAS No. 113474-59-2

Naphthalene, decahydro-1,6-bis(methylene)-3-(1-methylethyl)-

Catalog No.:AG0008ON MDL No.:

MF:C15H24 MW:204.3511

CAS No. 113474-85-4

Propanamide, 2-(acetyloxy)-N-methoxy-N-methyl-, (S)- (9CI)

Catalog No.:AG0008PV MDL No.:

MF:C7H13NO4 MW:175.1824

CAS No. 113474-86-5

2-Propenamide, N-methoxy-N-methyl-3-phenyl-, (2E)-

Catalog No.:AG0008PU MDL No.:MFCD01823330

MF:C11H13NO2 MW:191.2264

CAS No. 113474-90-1

2-Heptyn-1-one, 1-cyclohexyl-

Catalog No.:AG0008PT MDL No.:

MF:C13H20O MW:192.2973

CAS No. 113475-33-5

Benzene, [dichloro(1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl)silyl]-

Catalog No.:AG0008PS MDL No.:

MF:C16H20Cl2Si MW:311.3215

CAS No. 113475-65-3

Benzenamine, 4,5-diethoxy-2-nitro-

Catalog No.:AG0008PR MDL No.:MFCD02103697

MF:C10H14N2O4 MW:226.2292

CAS No. 1134753-48-2

1H-Indol-6-amine, 4-bromo-, hydrochloride (1:1)

Catalog No.:AG0008PB MDL No.:

MF:C8H8BrClN2 MW:247.5195

CAS No. 1134759-39-9

Bicyclo[3.1.0]hexane-3-carboxylic acid, 6,6-dichloro-3-[[(1,1-dimethylethoxy)carbonyl]amino]-

Catalog No.:AG0008PA MDL No.:MFCD04115621

MF:C12H17Cl2NO4 MW:310.1737

CAS No. 113476-33-8

2-Pentalenecarboxylic acid, 1,3a,4,5,6,6a-hexahydro-

Catalog No.:AG0008PQ MDL No.:

MF:C9H12O2 MW:152.1904

CAS No. 113476-62-3

2,10-Phenanthrenediol, 5,6,7-trimethoxy-, 2,10-diacetate

Catalog No.:AG0008PP MDL No.:

MF:C21H20O7 MW:384.3793

CAS No. 113476-63-4

Phenanthrene, 2,3,4,7,9-pentamethoxy-

Catalog No.:AG0008PO MDL No.:

MF:C19H20O5 MW:328.3591

CAS No. 113477-11-5

4,8-Dodecadien-1-ol, 12,12-dimethoxy-, (Z,Z)- (9CI)

Catalog No.:AG0008PN MDL No.:

MF:C14H26O3 MW:242.3544

CAS No. 113477-44-4

Magnesium, bromo(3-methyl-1,2-butadien-1-yl)-

Catalog No.:AG0008PM MDL No.:

MF:C5H7BrMg MW:171.3181

CAS No. 113477-48-8

Quinoxaline, 2-methyl-3-(2-propen-1-yl)-

Catalog No.:AG0008PL MDL No.:

MF:C12H12N2 MW:184.2371

CAS No. 113477-56-8

Quinoxaline, 2-methyl-3-(2-propyn-1-yl)-

Catalog No.:AG0008PK MDL No.:

MF:C12H10N2 MW:182.2212

CAS No. 113477-68-2

Quinoxaline, 1,2-dihydro-3-methyl-2-(2-propen-1-yl)-

Catalog No.:AG0008PJ MDL No.:

MF:C12H14N2 MW:186.2530

CAS No. 113477-72-8

Quinoxaline, 1,2,3,4-tetrahydro-2-(2-methyl-2-propen-1-yl)-

Catalog No.:AG0008PI MDL No.:

MF:C12H16N2 MW:188.2688

CAS No. 113477-73-9

Quinoxaline, 1,2,3,4-tetrahydro-2-(1-methyl-2-propen-1-yl)-

Catalog No.:AG0008PH MDL No.:

MF:C12H16N2 MW:188.2688

CAS No. 113477-78-4

6H-1,3-Thiazine-4-methanol, 5-(1,3-dioxolan-2-yl)-2-phenyl-

Catalog No.:AG0008PG MDL No.:

MF:C14H15NO3S MW:277.3388

CAS No. 113477-86-4

Benzonitrile, 4-[(2,5-dioxo-4-imidazolidinylidene)methyl]-

Catalog No.:AG0008PF MDL No.:

MF:C11H7N3O2 MW:213.1922

CAS No. 113477-87-5

9-Thiabicyclo[6.1.0]nonane, (1R,8S)-rel-

Catalog No.:AG0008PE MDL No.:

MF:C8H14S MW:142.2618

CAS No. 1134776-30-9

Benzoic acid, 4-[(1R)-1-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-

Catalog No.:AG0008P9 MDL No.:MFCD11505986

MF:C14H19NO4 MW:265.3050

CAS No. 1134776-39-8

Benzoic acid, 4-[(1R)-1-aminoethyl]-, hydrochloride (1:1)

Catalog No.:AG0008P8 MDL No.:MFCD09832182

MF:C9H12ClNO2 MW:201.6501

CAS No. 1134777-51-7

Benzoic acid, 4-(dibromomethyl)-3-fluoro-, methyl ester

Catalog No.:AG0008P7 MDL No.:

MF:C9H7Br2FO2 MW:325.9571

CAS No. 113478-79-8

1-Propanone, 2-bromo-3-(4-chlorophenyl)-1-phenyl-

Catalog No.:AG0008QK MDL No.:

MF:C15H12BrClO MW:323.6122

CAS No. 113478-91-4

2,4-Pentanedione, 3-(2-chloro-2-propen-1-yl)-

Catalog No.:AG0008QJ MDL No.:

MF:C8H11ClO2 MW:174.6247

CAS No. 113478-92-5

2,4-Pentanedione, 3-(2-bromo-2-propen-1-yl)-

Catalog No.:AG0008QI MDL No.:

MF:C8H11BrO2 MW:219.0757

CAS No. 113479-11-1

Butanoic acid, 3-methyl-3-[(phenylmethyl)amino]-

Catalog No.:AG0008QH MDL No.:MFCD18375304

MF:C12H17NO2 MW:207.2689

CAS No. 113479-13-3

2-Azetidinone, 1-cyclohexyl-3-methyl-

Catalog No.:AG0008QG MDL No.:

MF:C10H17NO MW:167.2481

CAS No. 113479-15-5

2-Propenoic acid, 3-(benzoylamino)-2-(mercaptomethyl)-, methyl ester

Catalog No.:AG0008QF MDL No.:

MF:C12H13NO3S MW:251.3015

CAS No. 113479-88-2

2-Azetidinone, 4-(3-phenyl-2-propyn-1-yl)-

Catalog No.:AG0008QE MDL No.:

MF:C12H11NO MW:185.2218

CAS No. 113480-03-8

2-Cyclohexen-1-one, 3-(4-butoxyphenyl)-6-pentyl-

Catalog No.:AG0008QD MDL No.:

MF:C21H30O2 MW:314.4617

CAS No. 113480-04-9

Cyclohexanone, 5-(4-butoxyphenyl)-2-pentyl-, trans- (9CI)

Catalog No.:AG0008QC MDL No.:

MF:C21H32O2 MW:316.4776

CAS No. 113480-18-5

Pyridinium, 1-(2-hydroxyethyl)-4-[2-(1-naphthalenyl)ethenyl]-

Catalog No.:AG0008QB MDL No.:

MF:C19H18NO+ MW:276.3523

CAS No. 113480-19-6

Glycine, L-tyrosyl-L-prolyl-L-leucyl-

Catalog No.:AG0008QA MDL No.:

MF:C22H32N4O6 MW:448.5127

CAS No. 113482-47-6

10-Undecenoic acid, 11-nitro-, methyl ester

Catalog No.:AG0008Q9 MDL No.:

MF:C12H21NO4 MW:243.2994

CAS No. 1134834-95-9

Cyclopropanamine, 1-(4-methylphenyl)-, hydrochloride (1:1)

Catalog No.:AG0008PW MDL No.:MFCD07995725

MF:C10H14ClN MW:183.6779

CAS No. 113484-74-5

Glycine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 2,5-dioxo-1-pyrrolidinyl ester

Catalog No.:AG0008Q8 MDL No.:MFCD00065651

MF:C21H18N2O6 MW:394.3774

CAS No. 113485-19-1

Acetic acid, 2-[(3,5,6-trichloro-2-pyridinyl)oxy]-, 1-methylethyl ester

Catalog No.:AG0008Q7 MDL No.:

MF:C10H10Cl3NO3 MW:298.5503

CAS No. 113485-20-4

Furan, 2-(2-bromoethynyl)-5-nitro-

Catalog No.:AG0008Q6 MDL No.:

MF:C6H2BrNO3 MW:215.9890

CAS No. 113485-26-0

Pyridine, 4-[5-(4-fluorophenyl)-2-oxazolyl]-

Catalog No.:AG0008Q5 MDL No.:

MF:C14H9FN2O MW:240.2325

CAS No. 113485-32-8

Carbamic acid, hydroxymethyl-, [1,1'-biphenyl]-4-ylmethyl ester (9CI)

Catalog No.:AG0008Q4 MDL No.:

MF:C15H15NO3 MW:257.2845

CAS No. 113485-46-4

Benzoyl chloride, 3,5-dichloro-4-methyl-

Catalog No.:AG0008Q3 MDL No.:MFCD11557536

MF:C8H5Cl3O MW:223.4837

CAS No. 113485-71-5

3-Buten-2-ol, 1-(hexadecyloxy)-

Catalog No.:AG0008Q2 MDL No.:

MF:C20H40O2 MW:312.5304

CAS No. 113485-72-6

Benzene, [[[1-[(hexadecyloxy)methyl]-2-propen-1-yl]oxy]methyl]-

Catalog No.:AG0008Q1 MDL No.:

MF:C27H46O2 MW:402.6529

CAS No. 113485-76-0

Oxirane, 2-[2-(hexadecyloxy)ethyl]-

Catalog No.:AG0008Q0 MDL No.:

MF:C20H40O2 MW:312.5304

CAS No. 113485-85-1

2-Hexyne, 1,1,1-triethoxy-5-methyl-

Catalog No.:AG0008PZ MDL No.:

MF:C13H24O3 MW:228.3279

CAS No. 113488-11-2

2-Butenedinitrile, 2,3-bis[2-[2-(methylseleno)phenyl]-2-phenylethenyl]-

Catalog No.:AG0008QW MDL No.:

MF:C34H26N2Se2 MW:620.5036

CAS No. 113488-13-4

Benzene, 1-methoxy-2-[(2-methoxy-2,2-diphenylethyl)seleno]-

Catalog No.:AG0008QV MDL No.:

MF:C22H22O2Se MW:397.3689

CAS No. 113489-32-0

3-Cyclohexene-1-carboxamide, N-methoxy-N-methyl-

Catalog No.:AG0008QU MDL No.:MFCD22414353

MF:C9H15NO2 MW:169.2209

CAS No. 113490-76-9

L-Proline, 4-(phenylmethoxy)-, methyl ester, (4R)-

Catalog No.:AG0008QT MDL No.:MFCD09878836

MF:C13H17NO3 MW:235.2790

CAS No. 1134915-25-5

Benzeneacetic acid, α-amino-3-(trifluoromethyl)-, hydrochloride (1:1)

Catalog No.:AG0008QN MDL No.:MFCD07371458

MF:C9H9ClF3NO2 MW:255.6215

CAS No. 1134915-37-9

3-Pyridineacetic acid, α-amino-6-phenyl-, hydrochloride (1:1)

Catalog No.:AG0008QM MDL No.:MFCD07371470

MF:C13H13ClN2O2 MW:264.7075

CAS No. 113492-12-9

1,3-Dioxolo[4,5-f][1,4]diazocine (9CI)

Catalog No.:AG0008QS MDL No.:MFCD18805911

MF:C7H6N2O2 MW:150.1347

CAS No. 1134924-86-9

1H-Pyrazole-4-methanamine, 1-(2-fluorophenyl)-

Catalog No.:AG0008QL MDL No.:

MF:C10H10FN3 MW:191.2049

CAS No. 113493-33-7

9H-Xanthen-9-ol, 9-[4-(dimethylamino)phenyl]-

Catalog No.:AG0008QR MDL No.:

MF:C21H19NO2 MW:317.3811

CAS No. 113493-36-0

9H-Fluoren-9-ol, 9-[4-(dimethylamino)phenyl]-

Catalog No.:AG0008QQ MDL No.:

MF:C21H19NO MW:301.3817

CAS No. 113493-42-8

2-Cyclohexen-1-ol, 1-(2-pyridinyl)-

Catalog No.:AG0008QP MDL No.:

MF:C11H13NO MW:175.2270

CAS No. 113493-51-9

Acetic acid, 2-[(dimethoxyphosphino)oxy]-, methyl ester

Catalog No.:AG0008QO MDL No.:

MF:C5H11O5P MW:182.1116

CAS No. 405509-32-2

CAS (cationizing agent) (9CI)

Catalog No.:AG0008PY MDL No.:

MF: MW:

CAS No. 832743-17-6

CAS (flocculant)

Catalog No.:AG0008PX MDL No.:

MF: MW:

© 2019 Angene International Limited. All rights Reserved.